웨어러블 인공 장기 시장 규모, 점유율, 동향 분석 리포트 : 인공 장기별, 기술별, 지역별, 부문 예측(2025-2030년)

Wearable Artificial Organs Market Size, Share & Trends Analysis Report By Artificial Organ (Kidney, Pancreas, Cochlear Implant, Exoskeleton, Bionic Limbs, Brain Bionics, Vision Bionics), By Technology, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

웨어러블 인공 장기 시장 성장과 동향

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 웨어러블 인공 장기 시장 규모는 2025-2030년에 17.2%의 CAGR을 기록하며, 2030년까지 287억 4,000만 달러에 달할 전망입니다.

장기 기증자 부족과 이식 실패 사례 증가는 이식 실패 사례 증가와 함께 착용형 인공 장기의 대규모 성장 기회를 창출하고 있으며, 3D 프린팅과 인공지능 분야의 기술 발전은 시장에 새로운 길을 열어주고 있습니다.

이러한 기기들은 치료와 투석을 받으면서도 일상생활을 계속할 수 있도록 함으로써 환자의 삶의 질을 향상시키고 있습니다. 이 시장에서는 향후 여러 제품이 출시되거나 FDA 승인을 받을 것으로 예상됩니다. 예를 들어 2019년 12월 FDA는 Tandem Diabetes Care의 Control-IQ 인공췌장 시스템을 승인했습니다. 2019년 8월 FDA는 편측 비대칭성 난청을 위한 MED-EL 인공와우 시스템을 승인했으며, 2019년 12월에는 Tandem Diabetes Care의 Control-IQ 인공췌장 시스템을 승인했습니다. 이 시스템은 5세 이상의 어린이에게 사용하도록 승인되었습니다.

중상을 입는 교통사고 증가도 착용형 인공장기에 대한 수요를 창출하고 있습니다. 세계보건기구(WHO)에 따르면 매년 약 140만 명이 교통사고로 사망하고, 약 2,000만-5,000만 명이 사망에 이르지 않는 부상을 입습니다.

웨어러블 인공장기 시장 보고서 하이라이트

• 인공와우 부문은 2024년 29.5%의 매출 점유율로 시장을 장악할 것으로 예상되며, 이는 난청 치료에 있으며, 그 효과가 입증되었기 때문입니다. 인공와우는 중등도에서 중증의 난청 환자를 위한 표준 솔루션으로 자리 잡으며 채택률이 증가하고 있습니다.
• 2024년에는 전자 부문이 가장 큰 매출 점유율을 차지하며 시장을 장악했습니다.
• 북미 웨어러블 인공장기 시장은 2024년 44.2%의 매출 점유율로 세계 시장을 장악했습니다. 이는 혁신적인 의료 기술의 급속한 발전과 채택을 지원하는 첨단 의료 인프라에 기인합니다.
• 아시아태평양의 웨어러블 인공장기 시장은 예측 기간 중 19.2%의 가장 높은 CAGR을 나타낼 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 웨어러블 인공 장기 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 웨어러블 인공 장기 시장 : 인공 장기 비즈니스 분석

• 인공 장기 시장 점유율, 2024년과 2030년
• 인공 장기 부문 대시보드
• 인공 장기에 의한 시장 규모와 예측과 동향 분석, 2018-2030년
• 신장
• 췌장
• 인공와우
• 외골격
• Bionic Limbs
• 브레인 바이오닉스
• 비전 바이오닉스

제5장 웨어러블 인공 장기 시장 : 기술 비즈니스 분석

• 기술 시장 점유율, 2024년과 2030년
• 기술 부문 대시보드
• 시장 규모와 예측과 동향 분석, 기술별, 2018-2030년
• 기계
• 전자

제6장 웨어러블 인공 장기 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 참가자 개요
• 기업의 시장 현황 분석
• 기업 분류
• 전략 지도제작
• 기업 개요/상장기업
  • Medtronic
  • Vivance
  • Vivani Medical, Inc.
  • Cochlear Ltd.
  • Ekso Bionics
  • MED-EL Medical Electronics
  • Abbott
  • Boston Scientific Corporation
  • HDT Global
  • BLS Systems Limited

KSA

영문 목차

영문목차

Wearable Artificial Organs Market Growth & Trends:

The global wearable artificial organs market size is expected to reach USD 28.74 billion by 2030, registering a CAGR of 17.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing cases of transplant failure coupled with the increasing shortage of organ donors are creating massive growth opportunities for wearable artificial organs. Technological advancement in the field of 3D printing and artificial intelligence is creating new avenues for the market.

These devices are improving the patient's quality of life by allowing them to continue their routine activities while undergoing therapy or dialysis. The market is expected to witness several product launches and FDA approvals. For instance, in December 2019, the FDA approved Tandem Diabetes Care's Control-IQ artificial pancreas system. The device is an automatic insulin dosing system designed to deliver correction boluses. In August 2019, the FDA approved a MED-EL cochlear implant system for single-sided asymmetric hearing loss. This system is approved for use in children 5 years and older.

Increasing incidence of road accidents resulting in severe injuries also creates a demand for wearable artificial organs. According to the World Health Organization, approximately 1.4 million people die in a road accident every year, and around 20 to 50 million people suffer from non-fatal injuries.

Wearable Artificial Organs Market Report Highlights:

• The cochlear implant segment dominated the market with a revenue share of 29.5% in 2024, which can be attributed to its established efficacy in treating hearing loss. Cochlear implants have become a standard solution for individuals with severe to profound hearing impairment, leading to increased adoption rates.
• The electronic segment dominated the market with the largest revenue share in 2024, which can be attributed to advancements in electronic components that enhance device performance and patient comfort.
• North America wearable artificial organs market dominated the global market with a revenue share of 44.2% in 2024, which can be attributed to advanced healthcare infrastructure that supports the rapid development and adoption of innovative medical technologies.
• The Asia Pacific wearable artificial organs market is expected to register the highest CAGR of 19.2% over the forecast period, which can be attributed to the large patient pool and the high incidence of organ failure in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Artificial Organ
  • 1.2.2. Technology
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Wearable Artificial Organs Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Wearable Artificial Organs Market: Artificial Organ Business Analysis

• 4.1. Artificial Organ Market Share, 2024 & 2030
• 4.2. Artificial Organ Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Artificial Organ, 2018 to 2030 (USD Million)
• 4.4. Kidney
  • 4.4.1. Kidney Market, 2018 - 2030 (USD Million)
• 4.5. Pancreas
  • 4.5.1. Pancreas Market, 2018 - 2030 (USD Million)
• 4.6. Cochlear Implant
  • 4.6.1. Cochlear Implant Market, 2018 - 2030 (USD Million)
• 4.7. Exoskeleton
  • 4.7.1. Exoskeleton Market, 2018 - 2030 (USD Million)
• 4.8. Bionic Limbs
  • 4.8.1. Bionic Limbs Market, 2018 - 2030 (USD Million)
• 4.9. Brain Bionics
  • 4.9.1. Brain Bionics Market, 2018 - 2030 (USD Million)
• 4.10. Vision Bionics
  • 4.10.1. Vision Bionics Market, 2018 - 2030 (USD Million)

Chapter 5. Wearable Artificial Organs Market: Technology Business Analysis

• 5.1. Technology Market Share, 2024 & 2030
• 5.2. Technology Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. Mechanical
  • 5.4.1. Mechanical Market, 2018 - 2030 (USD Million)
• 5.5. Electronic
  • 5.5.1. Electronic Market, 2018 - 2030 (USD Million)

Chapter 6. Wearable Artificial Organs Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Wearable Artificial Organs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Wearable Artificial Organs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Wearable Artificial Organs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Wearable Artificial Organs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Wearable Artificial Organs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Wearable Artificial Organs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Medtronic
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Vivance
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Vivani Medical, Inc.
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Cochlear Ltd.
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Ekso Bionics
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. MED-EL Medical Electronics
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Abbott
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Boston Scientific Corporation.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. HDT Global
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. BLS Systems Limited
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives

관련자료